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Abstract 
Purpose:  To evaluate the effects of a referral process on diabetic retinopathy screening rates 
among patients with Type 2 diabetes and formal documentation completion rates of these 
screenings within a primary care setting.   
Methods:  A referral process for patient referral to an ophthalmologist for annual diabetic 
retinopathy screening was instituted for a 4-week period within a Norton Community Medical 
Associates (NCMA) primary care location for Type 2 diabetes patients. Charts of 30 patients 
pre-intervention were compared with the charts of 30 patients seen during the intervention phase 
of the study to evaluate the effects of the referral intervention. Demographic data, including age, 
race, gender, and type of insurance, along with clinical data, including most recent Hgb A1C 
level, were collected for data analysis comparison. 
Results: There was no statistically significant difference between the demographic and clinical 
data collected from the pre- and post-intervention groups. Additionally, the difference in referral 
rates and formal documentation rates for the two groups was not statistically significant 
(p>0.05). 
Conclusion: A process improvement project using a brief referral intervention in a primary care 
setting showed no effect. Further study into this type of intervention to increase diabetic 
retinopathy screening rates in Type 2 diabetes patients and formal documentation completion 
rates of these screenings may be more beneficial if performed over a longer study period with 
evaluation of barriers preventing success at set time points during the study.  
Keywords: Type 2 diabetes, diabetic retinopathy, dilated fundus examination, referral, 
intervention, ophthalmology, documentation  
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A Process Improvement Project to Increase Diabetic Retinopathy Screening Rates as  
Evidenced by Formal Documentation 
Background 
Approximately 4.2 million Americans greater than age 65 years are affected by diabetic 
retinopathy, a disease in which elevated blood glucose causes damage to the tiny blood vessels in 
the retina of the eye (Weiss et al., 2015). Without effective healthcare interventions, the number 
of people affected by diabetic retinopathy is expected to increase to three times that amount by 
2050 (Zangalli et al., 2016). It is also estimated that, in 2004, more than $500 million was spent 
on direct and indirect healthcare costs related to blindness caused by diabetic retinopathy and its 
complications (Weiss et al., 2015). As the primary cause of new-onset blindness among 
Americans aged 20 to 74 years (Weiss et al., 2015), this expected increase in the number of cases 
of diabetic retinopathy will create a substantial and costly healthcare burden (Zangalli et al., 
2016).  
Because diabetic retinopathy is asymptomatic in its early stages (Sheppler, Lambert, 
Gardiner, Becker, & Mansberger, 2014) and because early detection of retinopathic changes by 
annual dilated fundus examination is essential in the prevention of serious eye complications and 
blindness (Walker, Schechter, Caban, & Basch, 2008), the American Diabetes Association 
recommends that all individuals with Type 2 diabetes have a comprehensive dilated eye 
examination soon after diagnosis (American Diabetes Association [ADA], 2013). Additionally, 
according to the American Optometric Association’s “Evidence-based Clinical Practice 
Guideline: Eye Care of the Patient with Diabetes Mellitus,” individuals with diabetes should 
receive dilated eye examinations at least yearly and more frequently if they have changes in 
vision or have diabetic retinopathy that is severe or progressing (American Optometric 
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Association [AOA], 2014). However, compliance rates in obtaining annual dilated fundus 
examinations remain low, with fewer than half of people with diabetes obtaining this annual 
screening and with 50% of those that comply being screened too late for optimal treatment 
(Weiss et al., 2015).  
The issue further intensifies when considering that primary care providers are held at a 
higher accountability for their patients receiving yearly screenings such as diabetic retinopathy 
examinations. With yearly dilated fundus examinations now being part of one of the HEDIS 
measurements, primary care providers risk changes in reimbursement when their diabetic 
patients do not successfully complete this exam and/or when they cannot provide formal, written 
documentation showing that their patients have had this service performed (Centers for Medicare 
and Medicaid Services [CMS], 2015). 
With the severity of the issue increasing in numbers and in costs, the question becomes, 
“What are the most efficient healthcare interventions for promoting yearly diabetic eye exam 
compliance in patients with Type 2 diabetes mellitus, and what is the best method of tracking 
overall compliance rates?” 
According to literature sources, interventions that contain an educational component that 
emphasizes the importance of annual dilated fundus examinations along with a personal 
component that helps patients overcome perceived barriers in getting the examinations may be 
the most effective in improving yearly examination compliance (Brunisholz et al., 2014; 
Sheppler et al., 2014; Walker et al., 2008; Weiss et al., 2015; & Zangalli et al., 2016). The 
purpose of this paper is to evaluate the effects of a referral process on diabetic retinopathy 
screening rates and formal documentation completion rates of these screenings among patients 
with Type 2 diabetes in a primary care setting. 
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Literature Review 
A literature search was conducted to identify articles with interventions that focused on 
the improvement of annual dilated fundus examination rates among people with diabetes. The 
search terms were diabetes OR diabetic in the title AND intervention OR education in the title or 
abstract AND eye OR fundus OR retinal OR vision in the title or abstract. The database used in 
the search was PubMed.   
Inclusion criteria for articles were: published between 2006 and 2016, written in English, 
full-text available, peer-reviewed, and focused on human species. Exclusion criteria were: 
studies that were not solely diabetes-focused, studies that concentrated only on Type 1 diabetes, 
and studies that did not involve an intervention that explored annual dilated fundus examination 
rates. A total of 103 articles were retrieved using the inclusion criteria. Five of these 103 articles 
were chosen overall for this literature review once the exclusion criteria were applied.  
Three of the reviewed studies were randomized controlled trials with one of these three 
having a fairly large sample size of n=1,920. The overall levels of evidence among the studies 
included four Level B studies as defined by the American Association of Critical-Care Nurses 
(AACN) and one Level C study as defined by AACN (Melnyk & Fineout-Overholt, 2011). A 
Level A meta-analysis of multiple controlled trials (Melnyk & Fineout-Overholt, 2011) that 
specifically targeted interventions that improved annual dilated fundus compliance rates was not 
found in the literature search.  
All five of the reviewed literature studies suggest that interventions that contain an 
educational component that emphasizes the importance of annual dilated fundus examinations 
along with a personal component that helps patients overcome perceived barriers in getting the 
examinations may be the most effective in improving annual dilated fundus examination 
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compliance (Brunisholz et al., 2014, Sheppler et al., 2014, Walker et al., 2008, Weiss et al., 
2015, and Zangalli et al., 2016). One of the five reviewed studies suggested a possible 
improvement in dilated fundus examination adherence with these two components present based 
on survey results (Sheppler et al., 2014). Additionally, four of the five studies reviewed 
suggested an improvement in dilated fundus examination compliance rates in the intervention 
group versus the control group when both of these components were present. Interventions in 
these four studies included a behavioral activation intervention versus supportive therapy, an 
education- and telephone-based intervention versus standard care, a telephone intervention 
versus printed materials, and a diabetic self-management education intervention versus standard 
care (Brunisholz et al., 2014, Walker et al., 2008, Weiss et al., 2015, and Zangalli et al., 2016).  
Purpose 
The overall purpose of this process improvement project was focused on increasing 
diabetic retinopathy screening rates among patients diagnosed with Type 2 diabetes by 
implementing a referral process in a primary care setting. More specifically, this project focused 
on the following objectives: 
a. Increase the number of referrals to ophthalmology for diabetic retinopathy 
screenings in Type 2 diabetes patients. 
b. Increase the number of diabetic retinopathy screenings that were formally 
documented in the patient’s electronic medical record. 
Methods 
Design 
This study was a process improvement project to improve diabetic retinopathy screening 
rates and formal documentation rates among patients with Type 2 diabetes. The results from this 
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study will serve as a pilot study for the feasibility and initial effects of the intervention. The 
study was conducted in four phases as follows: 
Phase 1: Prior to implementation of the intervention, a retrospective chart review was 
performed to evaluate current practice for referrals to ophthalmology for diabetic retinopathy 
screening and formal documentation of completion of these exams within the patient population 
of the primary care practice that was utilized for the project. 
Phase 2: The principal investigator (PI) educated the providers and supporting medical 
staff participating in the study about the process for referring Type 2 diabetes patients for 
diabetic retinopathy eye exams.  
Phase 3: After receiving education, the providers and office staff were instructed to 
follow the referral process for all patients that met the inclusion criteria. This phase was 
conducted over a 4-week period. 
Phase 4: A second chart review was conducted after the 4-week period to evaluate the 
number of patients that were properly referred for a diabetic retinopathy eye exam and the 
number of cases in which formal documentation of these screenings was received back from the 
ophthalmologist’s office.   
Study Population 
Provider Group: All of the providers within the designated Norton Community Medical 
Associates (NCMA) practice were invited to participate in the study. Only patient charts from 
participating providers who signed informed consent forms were audited after the educational 
intervention. Inclusion criteria for providers were licensed healthcare providers (physicians, 
nurse practitioners, or physician assistants) employed by Norton Healthcare (NHC). 
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Chart Review Group: Inclusion criteria for Phase 1 and 4 were medical records of 
patients with a diagnosis of Type 2 diabetes (ICD-10 codes of E11-E11.9) whose ages were 
between 18-70 years old. Exclusion criteria were medical records of patients whose age was 
outside of the specified age range of 18-70 years, those who did not have a current diagnosis of 
Type 2 diabetes, patients with Type 1 diabetes, and pregnant women.  
Permission to Conduct Study 
Permission to conduct the study was granted from the University of Kentucky (UK) 
Institutional Review Board (IRB) and from the Norton Healthcare Office of Research 
Administration (NHORA). As data collection from patient records was retrospective and de-
identified, a waiver of informed consent was granted. All prescribing medical providers were 
consented at a routine in-office staff meeting where they were given an informed consent form 
and asked to participate in the study. Supporting medical staff members were also educated at 
this time on their roles in the successfulness of the intervention. 
Procedures 
Phase 1: Needs Assessment. In order to conduct a needs assessment, a retrospective 
chart review of 30 patient medical records was completed to assess the designated NCMA 
office’s current diabetic retinopathy screening rates and the rates of formal documentation within 
their Type 2 diabetes patients’ medical records. The medical records were randomly selected 
from Type 2 patients seen in the practice for all appointment types between January 1, 2016 and 
December 31, 2016 that fit the inclusion and exclusion criteria previously discussed as 
characteristics of the chart review group. Charts for review were randomized by the IT 
Department at Norton Healthcare and sent to the primary investigator in an Excel spreadsheet 
with medical record numbers listed. The primary investigator assessed the medical records 
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through the EPIC electronic medical record (EMR). This was done in a private room with no 
other individuals present. Information including the number of referrals for dilated fundus 
screening performed, the number of diabetic retinopathy screenings reported and/or documented, 
and the number of patients in which formal documentation of screening was present in the EMR 
was obtained. Additionally, information on the patients’ age, race, gender, pregnancy status, type 
of insurance, and most recent Hgb A1C level was collected for data analysis comparison.  
Phase 2: Educational Intervention and Referral Process. To begin the intervention 
phase, the PI met with the NCMA providers and supporting medical staff to introduce the 
referral process and to answer questions regarding the implementation process. Education  
included the need for a referral protocol, the target patient population for the study, where to 
enter ophthalmology referrals into EPIC, and the process for making the patients’ ophthalmology 
appointments and faxing the patient documentation form at patient check-out.  
The referral process for patients that met the inclusion criteria was as follows. When 
patients came in for any appointment type and had a diagnosis of Type 2 diabetes in their 
electronic medical record, the primary care provider was to interview the patient and review the 
EMR to determine if the patient had completed their annual diabetic retinopathy screening by 
dilated fundus exam within the past 12 months. This discussion between the patient and the 
provider was to occur as part of the patient’s health maintenance assessment as per usual 
practice.  
If the patient stated that they had not had their annual screening, the primary care 
provider was instructed to enter a referral into the system to a local ophthalmologist of patient 
and/or provider choice. If the patient refused a referral, the provider was to enter a note in the 
referral section to document the refusal. Any education that the provider felt compelled to share 
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with the patient about the importance of the diabetic retinopathy exam should have taken place at 
this time as well. 
At check-out, the patient’s paperwork should have reflected the referral, alerting office 
staff members that they needed to aid the patient in scheduling their ophthalmology appointment. 
This assistance in scheduling the appointment for the patient was designed as part of the 
intervention as a personal component to help overcome any patient-perceived barriers to the 
screening, for this was a key factor in increasing screening rates as seen in the review of the 
literature. 
When making the appointment, the formal documentation form designed for this study 
was to be faxed to the referred ophthalmologist with instructions to fax it back upon completion 
of the diabetic retinopathy eye exam (see Appendix 1). If check-out paperwork stated the 
patient’s refusal for a referral, office staff was instructed to provide the formal documentation 
form to the patient for when or if they made their own ophthalmology appointment. Once the 
form was completed and faxed back to the NCMA office from the ophthalmology office showing 
completion of the diabetic retinopathy eye exam, NCMA office staff was educated to scan it into 
the system as a permanent part of the patient’s medical record.  
Phase 3: Implementation Phase. The implementation phase of the study lasted for 4 
weeks. During this phase, consenting providers conducted visits with their normal patient 
population and were to use the referral process on all Type 2 diabetes patients that met the 
inclusion criteria. Providers and staff were to follow all of the steps of the referral process 
described in Phase 2 during this time. The PI had no contact with patients during this phase, and 
contact with consenting providers was limited to providers contacting the PI with questions they 
had regarding the referral process.   
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Phase 4: Chart Review after 4-week Implementation Phase. The PI conducted a 
second chart review of the patient medical records from participating providers after the 4-week 
implementation phase. This chart review was performed on Type 2 diabetes patients that were 
seen during the implementation phase that fit the inclusion and exclusion criteria previously 
discussed as characteristics of the chart review group. Thirty charts were randomly selected by 
the IT Department at Norton Healthcare using the inclusion and exclusion criteria, and medical 
record numbers were sent to the PI within an Excel spreadsheet. Charts were reviewed 4 weeks 
after completion of the implementation phase as to allow time for completion of the scheduled 
ophthalmology exams and attainment of the formal documentation forms from ophthalmology to 
the primary care office. This chart review was conducted in a private room with no other 
individuals present.  
The 30 randomized charts of Type 2 diabetes patients seen for all appointment types 
during the implementation phase were reviewed for information including the number of 
referrals for dilated fundus screening performed, the number of diabetic retinopathy screenings 
reported and/or documented, the number of patients in which a referral was indicated at the time 
of their appointment, and the number of patients in which formal documentation of screening 
was received back from ophthalmology. Additionally, information on the patients’ age, race, 
gender, pregnancy status, type of insurance, and most recent Hgb A1C level was collected for 
data analysis comparison to pre-intervention data.  
Data Analysis 
Descriptive statistics, including means, standard deviations, and frequencies, were used to 
summarize the data for the pre- and post-intervention groups. Bivariate statistics, including the 
two-sample t-test and chi-square test of association, were used to compare demographic 
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characteristics between the two groups at each time. All data analysis was conducted using SPSS 
Version 22. An alpha level of 0.05 was used to determine statistical significance. 
Results 
 Within the NCMA, Mount Washington location, all 6 providers consented to participate 
in the study. Patient medical records that fit the inclusion and exclusion criteria previously 
discussed as characteristics of the chart review group were randomly selected by the IT 
Department at Norton Healthcare to fulfill the PI’s request of a pre-intervention group and a 
post-intervention group of 30 patients each. All 60 patient medical records that were reviewed 
met the inclusion and exclusion requirements. 
Bivariate statistics showed no statistically significant difference between the 
demographic and clinical data collected from the pre- and post-intervention groups (see Table 1).  
A two-sample t-test comparing age and most recent Hgb A1C and a chi-squared test of 
association comparing gender, race, and type of insurance payor showed that there was no  
statistically significant difference between the groups with a p-value >0.05 in all categories.  
The pre-intervention group had a mean age of 57.8 years and a mean last Hgb A1C of 
7.1. The group consisted of 40% males and 60% females with 96.7% being Caucasian. The post-
intervention had a mean age of 55.6 years and a mean last Hgb A1C of 7.7. The group consisted 
of 36.7% males and 63.3% females with 93.3% being Caucasian.  
After performing a chi-square test of association and obtaining a p-value >0.05, it was 
determined that the difference in referral rates and formal documentation rates for the two groups 
was not statistically significant (see Table 2). The pre-intervention indication of screening rate 
could not be assessed since the needs assessment chart review consisted of a review of all Type 2 
diabetes patient visits in the specified 12-month time period, and the diabetic retinopathy 
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screening is an every 12-month intervention. However, the post-intervention indication for 
screening rate could be assessed, and despite an indication for referral during the intervention 
phase of 66.7%, the referral rate for the pre- and post-intervention groups was unchanged at 
3.3%. Additionally, the formal documentation rate was less for the post-intervention group at 
13.3% compared to the pre-intervention rate of 26.7%. 
Discussion 
The brief referral intervention used in this process improvement project within a single 
primary care setting showed no effect. The two main objectives of the study were not met, as 
referral rates for diabetic retinopathy screenings did not increase nor did formal documentation 
completion rates of these screenings.  
The decrease in the formal documentation rates in the post-intervention group versus the 
pre-intervention group could likely be explained by the fact that the pre-intervention group’s rate 
was evaluated over a 12-month period, whereas the post-intervention group was only evaluated 
over a 1 to 2-month period, depending on when the post-intervention patients had their follow-up 
appointment within the intervention phase. An evaluation of the post-intervention group over a 
longer period of time to allow for more time for completion of diabetic retinopathy screenings 
likely would have increased this percentage. This decrease might also be explained by an issue 
with the form designed for this study not being properly routed to the ophthalmology office. An 
evaluation of the check-out and referral procedures after the patient was referred was not 
assessed but may have been useful.   
The unchanged referral rate pre-intervention versus post-intervention might be explained 
by the type of appointment the patient had scheduled, by time constraints inherent in providers’ 
busy schedules, and/or by expected and unexpected barriers that are often seen with change 
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processes. This could have been the case, for instance, if a Type 2 diabetes patient was being 
seen for a respiratory issue where the patient’s Type 2 diabetes was not the focus of the 
appointment. In this case, the illness might have taken precedence over any thought or emphasis 
on the diabetic retinopathy screening exam or even any diabetes treatment at all. Additionally, it 
might have been the case that the provider seeing the patient for the appointment simply forgot to 
refer, chose not to refer based on their personal knowledge of the patient, or ran out of time to 
refer for various reasons.  
Limitations 
The biggest limitation in this study was time. The intervention phase of the study was 
only 4 weeks long, and the post-intervention chart review was only performed on charts up to 4 
weeks after completion of the intervention phase. An intervention phase limited to such a small 
time window might have made it difficult for providers to remember to enact the change into 
their normal work routine, which could explain the limited number of referrals made to 
ophthalmology during the study. Additionally, a post-intervention chart review lasting only 4 
weeks after completion of the intervention phase may have been an inadequate time frame for 
patients to have their ophthalmology screenings performed, documentation of the screenings to 
be returned from ophthalmology, and/or documentation uploaded into the patients’ electronic 
medical records once returned. This could explain the decrease in formal documentation rates in 
comparison to the pre-intervention group. 
Another limitation of the study was an inability, mostly limited by time constraints, to 
evaluate how closely the referral intervention process was followed. The PI did not have any 
interaction with the providers or the staff during the intervention phase. As such, the providers 
were not reminded to put in referrals for diabetic retinopathy screenings, and the staff was not 
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reminded to fax the form designed for this study to the ophthalmologist office once a referral was 
made. Additionally, the forms that were faxed to ophthalmology were not kept for further review 
to evaluate if the process was correctly followed, and interviews about the process were not 
performed for adherence or barrier to adherence evaluation. All of these factors could have 
contributed to a lower than expected referral rate and formal documentation rate.  
Additional limitations of this study included a small sample size and homogenous 
demographics. Because this was a pilot study, only one primary care office seeing mostly 
Caucasian patients was studied, and only 60 charts in total were reviewed between the pre-
intervention and post-intervention groups. Related to these specific study limitations, the study 
findings do not allow for application to the general population, but they do hold significance for 
the particular primary care office studied.  
Implications for Clinical Practice 
Literature sources suggest that interventions that contain an educational component that 
emphasizes the importance of annual dilated fundus examinations along with a personal 
component that helps patients overcome perceived barriers in getting the examinations may be 
the most effective in improving annual dilated fundus examination compliance (Sheppler et al., 
2014, Walker et al., 2008, Weiss et al., 2015, and Zangalli et al., 2016). Patients in the literature 
studies were up to 2.5 times more likely to get their dilated retinopathy screenings when these 
two components were present (Walker et al., 2008, Weiss et al., 2015, and Zangalli et al., 2016). 
Nevertheless, this short-term pilot study in a primary care office showed no effect when an 
intervention that contained these components was implemented. However, future studies that 
include modifications to how this pilot study was implemented and evaluated may be beneficial 
in order to determine the true value of the type of intervention used in this study.  
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Further study performed over a longer study period with evaluation of barriers preventing 
success at set time points during the study might be especially useful. Evaluation of referral 
compliance when Type 2 diabetes patients are being seen specifically for diabetes follow-up 
appointments instead of all appointment types may also uncover unexpected barriers to referral. 
Additionally, a pre-designed educational handout, rather than varied verbal education, that 
providers could give patients that they refer to ophthalmology might better fit the necessary 
educational component uncovered in the literature review to increase screening compliance and 
formal documentation rates. Furthermore, an evaluation over an extended study period of all of 
the individuals that explicitly receive referrals during the intervention period versus just 
evaluating a random sample may give more insight into the effectiveness of the referral process 
on the receipt of formal documentation. And, allowing for a longer amount of time to assess 
compliance in patients from the intervention group completing their annual dilated fundus 
examination after they receive their referral may offer more insight into the true effect of the 
referral intervention on formal documentation rates. 
Conclusion 
 Annual dilated fundus examinations are the standard of care in the prevention of and 
complications from diabetic retinopathy in patients with Type 2 diabetes (Walker, Schechter, 
Caban, & Basch, 2008). Literature sources suggest that interventions that focus on education 
related to diabetic retinopathy exam importance and that help patients overcome barriers to 
exams may be the most successful at increasing compliance rates (Brunisholz et al., 2014; 
Sheppler et al., 2014; Walker et al., 2008; Weiss et al., 2015; & Zangalli et al., 2016). A brief 
referral intervention in a primary care setting that utilized these components showed no effect in 
compliance or formal documentation evidencing compliance, but study limitations may have 
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skewed the true capability of the intervention’s effect. Further study over a longer time period 
with modifications made to this study’s intervention is suggested to evaluate the potential effect 
of referral on dilated fundus exam compliance and formal documentation rates.   
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Table 1. Demographic and Clinical Data Summary (N=60) 
  
Pre-intervention (n=30) 
 
Post-intervention (n=30) 
 
p 
 
 
Age, Mean (SD) 
 
 
57.8 (9.3) 
 
 
55.6 (11.3) 
 
0.07 
 
Last Hgb A1C, Mean (SD) 
 
 
7.1 (1.4) 
 
 
7.7 (1.9) 
 
0.35 
 
Gender 
     Male 
     Female 
 
 
 
40% 
60% 
 
 
 
 
36.7% 
63.3% 
 
 
 
0.79 
 
Race 
     White  
     African American 
     Asian  
     Other 
 
 
 
96.7% 
3.3% 
0% 
0% 
 
 
 
 
93.3% 
0% 
3.3% 
3.3% 
 
 
0.39 
 
Payor Type 
     Private Insurance 
     Medicaid/Medicare 
   
 
 
63.3% 
36.7% 
 
 
 
 
46.7% 
53.3% 
 
 
 
0.19 
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Table 2. Frequency of Study Indicators (N=60) 
  
Pre-intervention (n=30) 
 
Post-intervention (n=30) 
 
p 
 
Referral Written 
 
 
3.3% 
 
3.3% 
 
1 
 
Patient-reported Exam 
 
 
43.3% 
 
33.3% 
 
0.43 
 
Formal Documentation 
 
 
26.7% 
 
13.3% 
 
0.20 
 
Referral Indicated 
 
 
Unable to assess 
 
66.7% 
 
N/A 
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Appendix 
 
Appendix 1: Diabetic Retinopathy Screening Form 
DIABETES EYE EXAM REFERRAL AND COMMUNICATION FORM 
PLEASE FAX THIS COMPLETED FORM TO THE REFERRING PRIMARY CARE PROVIDER 
UPON COMPLETION OF THE PATIENT VISIT 
 
To: Optometrist/Ophthalmologist 
 
Name:      ____________________________________________ 
Address:  ____________________________________________ 
Phone:     ____________________________________________ 
Fax:         ____________________________________________ 
Referral Information: 
 
_______________________________________________, from Norton Community Medical Associates 
Mt. Washington location has referred the following patient to you for a dilated retinal examination for 
evaluation of diabetic retinopathy: 
 
Patient Name:  ________________________________________    DOB:  _________________________ 
 
Insurance: ________________________   Date/time of scheduled exam: ___________________________ 
EYE EXAM REPORT: 
  
Please FAX this form to the referring Primary Care Provider at ________________________ upon 
completion of the patient visit. Please include your treatment plan.  
 
Retinal Examination Findings: 
  No diabetic retinopathy 
  Retinal abnormalities detected as follows: 
                       Non-proliferative changes noted in: 
                                 Right (Grade)        N/A     Mild     Moderate     Severe 
                                          Clinically significant diabetic macular edema?  Yes    No  
 
                                 Left (Grade)         N/A     Mild     Moderate     Severe 
                                          Clinically significant diabetic macular edema?  Yes    No  
 
                       Proliferative changes noted in: 
                                 Right (Grade)        N/A     Active     Regressed/Stable                                             
                                 Left (Grade)          N/A     Active     Regressed/Stable  
 
Other: __________________________________________________________________________ 
 
Recommended follow-up:      6 months     12 months    Other: ____________________ 
 
Additional Comments/Treatment Plan: ________________________________________________ 
 
________________________________________________________________________________ 
 
Signature: _________________________________    Date: ____________________ 
 
Adapted from the Massachusetts Health Promotion Clearinghouse, “Diabetes Eye Exam Referral 
and Communication Form,” 2017 
